Work

AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model

Year: 2013

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v122.21.240.240

Authors: Katharine Yen, Fang Wang, Jeremy Travins, Yue Chen, Hua Yang, Kim Straley, Sung Choe, Marion Dorsch, David P. Schenkein, Samuel Agresta, Scott Biller, Michael Su

Institution: Agios Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W172035505

Cites:

Cited by: 26

Related to: 10